European CommissionFirst calls for proposals under the Global Health EDCTP3 Joint Undertaking

The European and Developing Countries Clinical Trials Partnership (EDCTP) funds activities for research capacity building in Africa.

On May 10, the Global Health EDCTP3 Joint Undertaking published its 2022 Work Programme. The Work Programme document provides an overview of the work to be carried out throughout the course of 2022, including calls for proposals, as well as other aspects of the establishment of the Joint Undertaking.

Calls for proposals for 2022 include:

HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01: Promoting implementation of research results into policy and practice
HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02: Implementing adaptive platform trials
HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03: Genomic epidemiology for surveillance and control of poverty-related and emerging/re-emerging infections in sub-Saharan Africa – Partnership with the Bill & Melinda Gates Foundation
HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04: Creating a sustainable clinical trial network for infectious diseases in sub-Saharan Africa
HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05: Strengthening regulatory capacity for supporting conduct of clinical trials

Further information on these calls for proposals, including their scope and the objectives, can be found in the Funding and Tenders Opportunities Portal of the European Commission. All calls are currently open for submission and will close on August 30, 2022.

A Frequently Asked Questions (FAQ) document has been developed to provide further guidance on Work Programme 2022, including on funding eligibility.

Background

The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) builds on the first and second European and Developing Countries Clinical Trials Partnership programmes. This new joint undertaking is a partnership between the EU and the EDCTP Association, whose members include European and African countries.

This partnership will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.

By 2030, the GH EDCTP3 aims to develop and deploy at least two new technologies tackling infectious diseases, and support at least 100 research institutes in 30 countries to develop additional health technologies against infectious diseases.

More information

Back to Newsletter